These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33162820)

  • 1. Regulation of energy metabolism by combination therapy attenuates cardiac metabolic remodeling in heart failure.
    Huang Y; Zhang K; Jiang M; Ni J; Chen J; Li L; Deng J; Zhu Y; Mao J; Gao X; Fan G
    Int J Biol Sci; 2020; 16(16):3133-3148. PubMed ID: 33162820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted metabolomics and lipidomics uncovering the cardioprotective effects of Huanglian Jiedu Decoction on pathological cardiac hypertrophy and remodeling.
    Chen QQ; Wang FX; Cai YY; Zhang YK; Fang JK; Qi LW; Zhang L; Huang FQ
    J Ethnopharmacol; 2021 Apr; 270():113646. PubMed ID: 33264659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMP-activated protein kinase in the control of cardiac metabolism and remodeling.
    Horman S; Beauloye C; Vanoverschelde JL; Bertrand L
    Curr Heart Fail Rep; 2012 Sep; 9(3):164-73. PubMed ID: 22767403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
    Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
    Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanxinning injection ameliorates cardiac remodeling in HF mouse and 3D heart spheroid models via p38/FOS/MMP1-mediated inhibition of myocardial hypertrophy and fibrosis.
    Fan S; Xiao G; Ni J; Zhao Y; Du H; Liang Y; Lv M; He S; Fan G; Zhu Y
    Biomed Pharmacother; 2023 Jun; 162():114642. PubMed ID: 37027988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.
    Hu D; Cui YX; Wu MY; Li L; Su LN; Lian Z; Chen H
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1525-H1537. PubMed ID: 32383996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression.
    Li R; Lu K; Wang Y; Chen M; Zhang F; Shen H; Yao D; Gong K; Zhang Z
    Biochem Biophys Res Commun; 2017 Mar; 485(1):69-75. PubMed ID: 28202417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
    Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YiQiFuMai Powder Injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway.
    Pang LZ; Ju AC; Zheng XJ; Li F; Song YF; Zhao Y; Gu YF; Chen FL; Liu CH; Qi J; Gao Z; Kou JP; Yu BY
    J Ethnopharmacol; 2017 Apr; 202():67-77. PubMed ID: 28237302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.
    Foster DB; Liu T; Kammers K; O'Meally R; Yang N; Papanicolaou KN; Talbot CC; Cole RN; O'Rourke B
    J Proteome Res; 2016 Sep; 15(9):3009-28. PubMed ID: 27399916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity.
    Karwi QG; Zhang L; Altamimi TR; Wagg CS; Patel V; Uddin GM; Joerg AR; Padwal RS; Johnstone DE; Sharma A; Oudit GY; Lopaschuk GD
    Diabetes Obes Metab; 2019 Aug; 21(8):1944-1955. PubMed ID: 31050157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction.
    Wang W; Zhang F; Xia Y; Zhao S; Yan W; Wang H; Lee Y; Li C; Zhang L; Lian K; Gao E; Cheng H; Tao L
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1160-H1169. PubMed ID: 27542406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism.
    Sung MM; Das SK; Levasseur J; Byrne NJ; Fung D; Kim TT; Masson G; Boisvenue J; Soltys CL; Oudit GY; Dyck JR
    Circ Heart Fail; 2015 Jan; 8(1):128-37. PubMed ID: 25394648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.
    Li X; Lu Q; Qiu Y; do Carmo JM; Wang Z; da Silva AA; Mouton A; Omoto ACM; Hall ME; Li J; Hall JE
    J Am Heart Assoc; 2021 Mar; 10(6):e018298. PubMed ID: 33719499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise-Induced Changes in Glucose Metabolism Promote Physiological Cardiac Growth.
    Gibb AA; Epstein PN; Uchida S; Zheng Y; McNally LA; Obal D; Katragadda K; Trainor P; Conklin DJ; Brittian KR; Tseng MT; Wang J; Jones SP; Bhatnagar A; Hill BG
    Circulation; 2017 Nov; 136(22):2144-2157. PubMed ID: 28860122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach.
    Lai L; Leone TC; Keller MP; Martin OJ; Broman AT; Nigro J; Kapoor K; Koves TR; Stevens R; Ilkayeva OR; Vega RB; Attie AD; Muoio DM; Kelly DP
    Circ Heart Fail; 2014 Nov; 7(6):1022-31. PubMed ID: 25236884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decomposing the Mechanism of Qishen Granules in the Treatment of Heart Failure by a Quantitative Pathway Analysis Method.
    Ren W; Gao S; Zhang H; Ren Y; Yu X; Lin W; Guo S; Zhu R; Wang W
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30041436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.